首页 > 最新文献

Obstetrician & Gynaecologist最新文献

英文 中文
Editorial 社论
IF 1.4 Pub Date : 2023-01-01 DOI: 10.1111/tog.12856
J. Morrison
{"title":"Editorial","authors":"J. Morrison","doi":"10.1111/tog.12856","DOIUrl":"https://doi.org/10.1111/tog.12856","url":null,"abstract":"","PeriodicalId":51862,"journal":{"name":"Obstetrician & Gynaecologist","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49285134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CPD questions for volume 25 issue 1 第25卷第1期CPD问题
IF 1.4 Pub Date : 2023-01-01 DOI: 10.1111/tog.12858
CPD credits can be claimed for the following questions online via the TOG CPD submission system in the RCOG CPD ePortfolio. You must be a registered CPD participant of the RCOG CPD programme (available in the UK and worldwide) in order to submit your answers. Completion of TOG true/false questions can be claimed as a Specific Learning Event. Participants can claim two credits per set of questions if at least 70% of questions have been answered correctly. CPDparticipants are advised to considerwhether the articles are still relevant for their CPD, in particular if there are more recent articles on the same topic available and if clinical guidelines have been updated since publication. Please direct all questions or problems to the CPD Office. Tel: +44 (0)20 7772 6307 or email: cpd@rcog.org.uk. The blue symbol denotes which source the questions refer to including the RCOG journals, TOG and BJOG, and RCOG guidance, such as Green-top Guidelines (GTGs) and Scientific Impact Papers (SIPs). All of the above sources are available to RCOG Members and Fellows via the RCOG website. RCOG Members, Fellows andAssociates have full access to TOGcontent via theWileyOnline Library app (available for iOS andAndroid).
以下问题可以通过RCOG CPD电子档案库中的TOG CPD提交系统在线申请CPD学分。您必须是RCOG CPD课程的注册参与者(可在英国和全球范围内使用)才能提交您的答案。完成TOG的真假问题可以作为一个特定的学习事件。如果答对70%以上的问题,每组问题可获得2分。建议CPD参与者考虑这些文章是否仍然与他们的CPD相关,特别是如果有更多关于同一主题的最新文章,以及临床指南自发表以来是否已经更新。请直接向CPD办公室提出所有问题或问题。电话:+44(0)20 7772 6307或电子邮件:cpd@rcog.org.uk。蓝色符号表示问题涉及的来源,包括RCOG期刊,TOG和BJOG,以及RCOG指南,如绿顶指南(gtg)和科学影响论文(sip)。RCOG成员和研究员可以通过RCOG网站获得上述所有资源。RCOG成员、研究员和合作伙伴可以通过wileyonline Library应用程序(适用于iOS和android)完全访问tog内容。
{"title":"CPD questions for volume 25 issue 1","authors":"","doi":"10.1111/tog.12858","DOIUrl":"https://doi.org/10.1111/tog.12858","url":null,"abstract":"CPD credits can be claimed for the following questions online via the TOG CPD submission system in the RCOG CPD ePortfolio. You must be a registered CPD participant of the RCOG CPD programme (available in the UK and worldwide) in order to submit your answers. Completion of TOG true/false questions can be claimed as a Specific Learning Event. Participants can claim two credits per set of questions if at least 70% of questions have been answered correctly. CPDparticipants are advised to considerwhether the articles are still relevant for their CPD, in particular if there are more recent articles on the same topic available and if clinical guidelines have been updated since publication. Please direct all questions or problems to the CPD Office. Tel: +44 (0)20 7772 6307 or email: cpd@rcog.org.uk. The blue symbol denotes which source the questions refer to including the RCOG journals, TOG and BJOG, and RCOG guidance, such as Green-top Guidelines (GTGs) and Scientific Impact Papers (SIPs). All of the above sources are available to RCOG Members and Fellows via the RCOG website. RCOG Members, Fellows andAssociates have full access to TOGcontent via theWileyOnline Library app (available for iOS andAndroid).","PeriodicalId":51862,"journal":{"name":"Obstetrician & Gynaecologist","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47007900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Key messages from the UK and Ireland Confidential Enquiries into Maternal Death and Morbidity 2022 2022年英国和爱尔兰孕产妇死亡和发病率机密调查的关键信息
IF 1.4 Pub Date : 2023-01-01 DOI: 10.1111/tog.12853
M. Knight
The latest report from the UK and Ireland Confidential Enquiries into Maternal Deaths and morbidity, the ninth in the now annual report format, includes surveillance and Confidential Enquiries covering the period 2018–2020. The report also includes reviews into the care of women who died during or after pregnancy in the Republic of Ireland as well as the UK. Following the annual topic-specific format, this report includes topic-specific reviews into the care of women who died from cardiovascular causes, hypertensive disorders and early pregnancy disorders and the care of women who died from mental health-related causes and accidents in 2020. The report also includes a Morbidity Confidential Enquiry into the care of women with diabetic ketoacidosis in pregnancy. Messages for improving the care of women with hypertensive disorders were also identified from reviews of babies who died or had brain injury conducted by the Healthcare Safety Investigation Branch (HSIB).
英国和爱尔兰孕产妇死亡和发病率机密调查的最新报告是目前年度报告格式中的第九份,包括2018-2020年期间的监测和机密调查。该报告还包括对爱尔兰共和国和英国妊娠期间或妊娠后死亡妇女护理的审查。按照年度专题格式,本报告包括对死于心血管原因的妇女护理的专题审查,2020年因精神健康原因和事故死亡的妇女的护理。该报告还包括一份关于妊娠期糖尿病酮症酸中毒妇女护理的发病率机密调查。医疗安全调查处(HSIB)对死亡或脑损伤婴儿的审查也发现了改善高血压疾病妇女护理的信息。
{"title":"Key messages from the UK and Ireland Confidential Enquiries into Maternal Death and Morbidity 2022","authors":"M. Knight","doi":"10.1111/tog.12853","DOIUrl":"https://doi.org/10.1111/tog.12853","url":null,"abstract":"The latest report from the UK and Ireland Confidential Enquiries into Maternal Deaths and morbidity, the ninth in the now annual report format, includes surveillance and Confidential Enquiries covering the period 2018–2020. The report also includes reviews into the care of women who died during or after pregnancy in the Republic of Ireland as well as the UK. Following the annual topic-specific format, this report includes topic-specific reviews into the care of women who died from cardiovascular causes, hypertensive disorders and early pregnancy disorders and the care of women who died from mental health-related causes and accidents in 2020. The report also includes a Morbidity Confidential Enquiry into the care of women with diabetic ketoacidosis in pregnancy. Messages for improving the care of women with hypertensive disorders were also identified from reviews of babies who died or had brain injury conducted by the Healthcare Safety Investigation Branch (HSIB).","PeriodicalId":51862,"journal":{"name":"Obstetrician & Gynaecologist","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48288513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Pitfalls of prenatal diagnosis associated with mosaicism 嵌合体相关的产前诊断缺陷
IF 1.4 Pub Date : 2022-12-20 DOI: 10.1111/tog.12850
K. Reilly, Samantha B. Doyle, S. Hamilton, M. Kilby, F. Mone
Fetal placental mosaicism, of which confined placental mosaicism is a subtype, occurs in 2–3% of pregnancies. Confined placental mosaicism may lead to a false positive result on non‐invasive prenatal testing (NIPT) for common aneuploidies. The risk of mosaicism in a chorionic villus sample (CVS) following a positive NIPT result is 2, 4, 22 and 59% for trisomy 21, 18, 13 and 45, X respectively. Following a positive NIPT result in the absence of a significant fetal structural anomaly (FSA), care is required in selecting the optimal diagnostic invasive test. Discussion of the limitations and implications is essential and referral to clinical genetics may be warranted.
胎儿胎盘嵌合体,其中局限性胎盘嵌合体是一种亚型,发生在2-3%的妊娠中。局限性胎盘嵌合体可能导致常见非整倍体的无创产前检测(NIPT)结果呈假阳性。NIPT结果呈阳性后,绒毛膜绒毛样本(CVS)中21、18、13和45,X三体的嵌合体风险分别为2%、4%、22%和59%。在没有明显胎儿结构异常(FSA)的情况下,NIPT结果呈阳性后,需要谨慎选择最佳的诊断性侵入性测试。对局限性和影响的讨论是至关重要的,可能需要转诊到临床遗传学。
{"title":"Pitfalls of prenatal diagnosis associated with mosaicism","authors":"K. Reilly, Samantha B. Doyle, S. Hamilton, M. Kilby, F. Mone","doi":"10.1111/tog.12850","DOIUrl":"https://doi.org/10.1111/tog.12850","url":null,"abstract":"Fetal placental mosaicism, of which confined placental mosaicism is a subtype, occurs in 2–3% of pregnancies. Confined placental mosaicism may lead to a false positive result on non‐invasive prenatal testing (NIPT) for common aneuploidies. The risk of mosaicism in a chorionic villus sample (CVS) following a positive NIPT result is 2, 4, 22 and 59% for trisomy 21, 18, 13 and 45, X respectively. Following a positive NIPT result in the absence of a significant fetal structural anomaly (FSA), care is required in selecting the optimal diagnostic invasive test. Discussion of the limitations and implications is essential and referral to clinical genetics may be warranted.","PeriodicalId":51862,"journal":{"name":"Obstetrician & Gynaecologist","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44451468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Valvular heart disease in pregnancy 妊娠期瓣膜性心脏病
IF 1.4 Pub Date : 2022-12-16 DOI: 10.1111/tog.12857
P. Timmons, G. Partridge, A. Mckelvey, H. Lyall, M. Morosan, L. Freeman
Pregnancy‐induced changes in haemodynamic physiology can place considerable strain on cardiac function in some women with valvular disease. Regurgitant valve lesions are usually better tolerated in pregnancy than stenotic lesions, although the risk of obstetric complications is increased in both. Pre‐conception counselling is essential for all women with valvular disease. Optimising anticoagulation is a particular challenge in women with mechanical valves.
妊娠引起的血液动力学生理学变化会对一些患有瓣膜病的女性的心脏功能造成相当大的压力。反流性瓣膜病变在妊娠期通常比狭窄病变耐受性更好,尽管两者都会增加产科并发症的风险。对于所有患有瓣膜病的女性来说,孕前咨询是必不可少的。对于使用机械瓣膜的女性来说,优化抗凝治疗是一个特别的挑战。
{"title":"Valvular heart disease in pregnancy","authors":"P. Timmons, G. Partridge, A. Mckelvey, H. Lyall, M. Morosan, L. Freeman","doi":"10.1111/tog.12857","DOIUrl":"https://doi.org/10.1111/tog.12857","url":null,"abstract":"Pregnancy‐induced changes in haemodynamic physiology can place considerable strain on cardiac function in some women with valvular disease. Regurgitant valve lesions are usually better tolerated in pregnancy than stenotic lesions, although the risk of obstetric complications is increased in both. Pre‐conception counselling is essential for all women with valvular disease. Optimising anticoagulation is a particular challenge in women with mechanical valves.","PeriodicalId":51862,"journal":{"name":"Obstetrician & Gynaecologist","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48877412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human papillomavirus‐independent cervical cancer and its precursor lesions 不依赖人乳头瘤病毒的宫颈癌及其前驱病变
IF 1.4 Pub Date : 2022-12-10 DOI: 10.1111/tog.12855
I. Aggarwal, Y. Yeo, Zheng Yuan Ng
With the move towards ubiquitous human papillomavirus (HPV) primary screening and increasing coverage with HPV vaccination, the prevalence of HPV‐associated cervical cancers is predicted to decrease. Clinicians must be aware of HPV‐independent adenocarcinomas, which are likely to increase as a proportion of the total diagnosed cervical adenocarcinomas. Advances in histopathology, immunohistochemistry and molecular genetics have increased our understanding of the spectrum of gastric‐type and other rare HPV‐independent adenocarcinomas. Clinical outcome and prognosis of HPV‐independent adenocarcinoma is worse than the HPV‐associated adenocarcinoma. There is a paucity of evidence‐based guidelines tailored to management of HPV‐independent adenocarcinomas.
随着普遍存在的人乳头瘤病毒(HPV)初级筛查和HPV疫苗接种覆盖率的提高,预计HPV相关宫颈癌的患病率将下降。临床医生必须意识到HPV非依赖性腺癌,这种腺癌在诊断的宫颈腺癌总数中所占比例可能会增加。组织病理学、免疫组织化学和分子遗传学的进展增加了我们对胃型和其他罕见的HPV非依赖性腺癌谱的了解。HPV非依赖性腺癌的临床结果和预后比HPV相关腺癌差。缺乏专门针对HPV非依赖性腺癌管理的循证指南。
{"title":"Human papillomavirus‐independent cervical cancer and its precursor lesions","authors":"I. Aggarwal, Y. Yeo, Zheng Yuan Ng","doi":"10.1111/tog.12855","DOIUrl":"https://doi.org/10.1111/tog.12855","url":null,"abstract":"With the move towards ubiquitous human papillomavirus (HPV) primary screening and increasing coverage with HPV vaccination, the prevalence of HPV‐associated cervical cancers is predicted to decrease. Clinicians must be aware of HPV‐independent adenocarcinomas, which are likely to increase as a proportion of the total diagnosed cervical adenocarcinomas. Advances in histopathology, immunohistochemistry and molecular genetics have increased our understanding of the spectrum of gastric‐type and other rare HPV‐independent adenocarcinomas. Clinical outcome and prognosis of HPV‐independent adenocarcinoma is worse than the HPV‐associated adenocarcinoma. There is a paucity of evidence‐based guidelines tailored to management of HPV‐independent adenocarcinomas.","PeriodicalId":51862,"journal":{"name":"Obstetrician & Gynaecologist","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46939444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Premenstrual disorders including premenstrual syndrome and premenstrual dysphoric disorder 月经前疾病,包括经前综合征和经前烦躁不安
IF 1.4 Pub Date : 2022-11-13 DOI: 10.1111/tog.12848
Nidhi Goswami, Kalpana Upadhyay, P. Briggs, Elizabeth Osborn, N. Panay
The spectrum of premenstrual disorders is related to hormonal changes in the menstrual cycle and are experienced by nearly 40% of women. Approximately 3–8% of women are affected by severe premenstrual syndrome, including premenstrual dysphoric disorder (PMDD); a chronic, debilitating disorder with severe emotional and physical symptoms and functional impairment. PMDD significantly affects women's quality of life; recent evidence suggests that 86% of patients have considered suicide, with 30% having attempted suicide at least once. In 2019, PMDD was added to the International Statistical Classification of Diseases and Related Health Problems, (ICD–11), which validates PMDD as a legitimate diagnosis and acknowledges growing scientific and medical understanding of this previously under recognised condition. Symptom relief can often be achieved through medical management, therefore it is important to increase awareness among healthcare professionals at all levels.
经前障碍的范围与月经周期中的激素变化有关,近40%的女性都经历过。大约有3-8%的女性患有严重的经前综合征,包括经前烦躁不安(PMDD);一种慢性衰弱性疾病,具有严重的情绪和身体症状以及功能损害。PMDD严重影响妇女的生活质量;最近的证据表明,86%的患者曾考虑过自杀,30%的患者至少有过一次自杀未遂。2019年,PMDD被添加到《国际疾病和相关健康问题统计分类》(ICD-11)中,该分类验证了PMDD是一种合法的诊断,并承认科学和医学界对这种以前未被认可的疾病的理解日益加深。症状缓解通常可以通过医疗管理来实现,因此提高各级医疗专业人员的意识很重要。
{"title":"Premenstrual disorders including premenstrual syndrome and premenstrual dysphoric disorder","authors":"Nidhi Goswami, Kalpana Upadhyay, P. Briggs, Elizabeth Osborn, N. Panay","doi":"10.1111/tog.12848","DOIUrl":"https://doi.org/10.1111/tog.12848","url":null,"abstract":"The spectrum of premenstrual disorders is related to hormonal changes in the menstrual cycle and are experienced by nearly 40% of women. Approximately 3–8% of women are affected by severe premenstrual syndrome, including premenstrual dysphoric disorder (PMDD); a chronic, debilitating disorder with severe emotional and physical symptoms and functional impairment. PMDD significantly affects women's quality of life; recent evidence suggests that 86% of patients have considered suicide, with 30% having attempted suicide at least once. In 2019, PMDD was added to the International Statistical Classification of Diseases and Related Health Problems, (ICD–11), which validates PMDD as a legitimate diagnosis and acknowledges growing scientific and medical understanding of this previously under recognised condition. Symptom relief can often be achieved through medical management, therefore it is important to increase awareness among healthcare professionals at all levels.","PeriodicalId":51862,"journal":{"name":"Obstetrician & Gynaecologist","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43798139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Postpartum perineal wound dehiscence 产后会阴伤口裂开
IF 1.4 Pub Date : 2022-11-10 DOI: 10.1111/tog.12846
Tarek El Shamy, Eleanor Sein, Sunita Sharma, C. Domoney
Articles in the Tips and Techniques section are personal views from experts in their field on how to carry out procedures in obstetrics and gynaecology.
提示和技术部分的文章是各自领域专家关于如何执行妇产科程序的个人观点。
{"title":"Postpartum perineal wound dehiscence","authors":"Tarek El Shamy, Eleanor Sein, Sunita Sharma, C. Domoney","doi":"10.1111/tog.12846","DOIUrl":"https://doi.org/10.1111/tog.12846","url":null,"abstract":"Articles in the Tips and Techniques section are personal views from experts in their field on how to carry out procedures in obstetrics and gynaecology.","PeriodicalId":51862,"journal":{"name":"Obstetrician & Gynaecologist","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48869619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Bartholin's cyst and abscess Bartholin囊肿和脓肿的治疗
IF 1.4 Pub Date : 2022-11-10 DOI: 10.1111/tog.12847
A.A. Bati‐Paracha, M. Sharma
Articles in the Tips and Techniques section are personal views from experts in their field on how to carry out procedures in obstetrics and gynaecology.
提示和技巧部分的文章是本领域专家对如何进行妇产科手术的个人观点。
{"title":"Management of Bartholin's cyst and abscess","authors":"A.A. Bati‐Paracha, M. Sharma","doi":"10.1111/tog.12847","DOIUrl":"https://doi.org/10.1111/tog.12847","url":null,"abstract":"Articles in the Tips and Techniques section are personal views from experts in their field on how to carry out procedures in obstetrics and gynaecology.","PeriodicalId":51862,"journal":{"name":"Obstetrician & Gynaecologist","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49532468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Management of term breech presentation 管理期末报告
IF 1.4 Pub Date : 2022-10-17 DOI: 10.1111/tog.12845
P. Timmons, Victoria A. Wallis, Shawn Walker, D. Alleemudder
While most breech babies are delivered by caesarean section, a small number are born vaginally. Detailed counselling and an accoucher skilled in vaginal breech birth (VBB) are essential for offering the modality. External cephalic version (ECV) is safe, acceptable to most women, has few contraindications and increases vaginal birth rates. Undiagnosed term breech presentation can largely be prevented by routine third‐trimester ultrasound. Research is needed to evaluate the efficacy of VBB simulation training in clinical practice.
虽然大多数臀位婴儿是通过剖腹产分娩的,但也有少数是通过阴道分娩的。详细的咨询和熟练的阴道臀位分娩(VBB)护理人员对于提供该模式至关重要。头外型(ECV)是安全的,大多数女性都能接受,几乎没有禁忌症,并且会增加阴道分娩率。常规的孕晚期超声检查可以在很大程度上预防未确诊的足月臀位。需要研究评估VBB模拟训练在临床实践中的效果。
{"title":"Management of term breech presentation","authors":"P. Timmons, Victoria A. Wallis, Shawn Walker, D. Alleemudder","doi":"10.1111/tog.12845","DOIUrl":"https://doi.org/10.1111/tog.12845","url":null,"abstract":"While most breech babies are delivered by caesarean section, a small number are born vaginally. Detailed counselling and an accoucher skilled in vaginal breech birth (VBB) are essential for offering the modality. External cephalic version (ECV) is safe, acceptable to most women, has few contraindications and increases vaginal birth rates. Undiagnosed term breech presentation can largely be prevented by routine third‐trimester ultrasound. Research is needed to evaluate the efficacy of VBB simulation training in clinical practice.","PeriodicalId":51862,"journal":{"name":"Obstetrician & Gynaecologist","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48603362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Obstetrician & Gynaecologist
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1